We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's Why You Should Retain Equifax (EFX) in Your Portfolio
Read MoreHide Full Article
Equifax Inc. (EFX - Free Report) has had an impressive run on the bourses over the past year. The stock has gained 31.1% against 27.8% decline of the industry it belongs to and 12.5% growth of the Zacks S&P 500 composite.
EFX has an impressive Growth Score of B. This style score condenses all the essential metrics from a company’s financial statements to get a true sense of the quality and sustainability of its growth.
Equifax’s 2022 and 2023 earnings are expected to improve 14.7% and 16.6%, respectively, year over year. Revenues are anticipated to rise a respective 7.9% and 9.4% in 2022 and 2023.
Factors That Bode Well
The company’s ongoing cloud data and technology transformation is aimed at driving innovation and product development, strengthening customer and partner integration and implementation. As part of the transformation, Equifax is migrating to a public cloud environment that engages virtual private cloud deployment techniques. The company remains focused on streamlining customers’ access to its analytical platforms.
Equifax remains focused on expanding and strengthening its customer base with efforts on delivering multi-data solutions through expanding differentiated data assets and analytics through organic growth, mergers and acquisitions and partnerships. The company uses proprietary advanced analytical platforms, machine learning, artificial intelligence and advanced visualization tools.
The recent acquisition of Efficient Hire, which is now part of Equifax’s Workforce Solutions business unit, expands the company's portfolio of employer- and HR-focused solutions, boosting its ability to help clients manage their hiring and employment needs.
Some Risks
Equifax has more long-term debt outstanding than cash. Cash and cash equivalent balance at the end of fourth-quarter 2021 was $224.7 million compared with the long-term debt level of $4.5 billion. Further, the cash level can't meet the short-term debt of $824.8 million.
Cross Country Healthcare delivered a trailing four-quarter earnings surprise of 41.5%, on average. CCRN’s shares have surged 88.1% in the past year.
Accenture carries a Zacks Rank #2 (Buy). The company has an expected earnings growth rate of 19.8% for the current year. It delivered a trailing four-quarter earnings surprise of 5.3%, on average.
Accenture’s shares have surged 22.9% in the past year. The company has a long-term earnings growth of 10%.
Clean Harbors’ carries a Zacks Rank #1. The company pulled off a trailing four-quarter earnings surprise of 43.2%, on average.
CLH’s shares have jumped 9.4% in the past year.
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
Here's Why You Should Retain Equifax (EFX) in Your Portfolio
Equifax Inc. (EFX - Free Report) has had an impressive run on the bourses over the past year. The stock has gained 31.1% against 27.8% decline of the industry it belongs to and 12.5% growth of the Zacks S&P 500 composite.
Equifax, Inc. Price
Equifax, Inc. price | Equifax, Inc. Quote
EFX has an impressive Growth Score of B. This style score condenses all the essential metrics from a company’s financial statements to get a true sense of the quality and sustainability of its growth.
Equifax’s 2022 and 2023 earnings are expected to improve 14.7% and 16.6%, respectively, year over year. Revenues are anticipated to rise a respective 7.9% and 9.4% in 2022 and 2023.
Factors That Bode Well
The company’s ongoing cloud data and technology transformation is aimed at driving innovation and product development, strengthening customer and partner integration and implementation. As part of the transformation, Equifax is migrating to a public cloud environment that engages virtual private cloud deployment techniques. The company remains focused on streamlining customers’ access to its analytical platforms.
Equifax remains focused on expanding and strengthening its customer base with efforts on delivering multi-data solutions through expanding differentiated data assets and analytics through organic growth, mergers and acquisitions and partnerships. The company uses proprietary advanced analytical platforms, machine learning, artificial intelligence and advanced visualization tools.
The recent acquisition of Efficient Hire, which is now part of Equifax’s Workforce Solutions business unit, expands the company's portfolio of employer- and HR-focused solutions, boosting its ability to help clients manage their hiring and employment needs.
Some Risks
Equifax has more long-term debt outstanding than cash. Cash and cash equivalent balance at the end of fourth-quarter 2021 was $224.7 million compared with the long-term debt level of $4.5 billion. Further, the cash level can't meet the short-term debt of $824.8 million.
Zacks Rank and Stocks to Consider
Equifax currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the broader Business Services sector that investors may consider are Cross Country Healthcare (CCRN - Free Report) , Accenture (ACN - Free Report) and Clean Harbors (CLH - Free Report) .
Cross Country Healthcare sports a Zacks Rank #1 (Strong Buy). The company has a long-term earnings growth of 6.6%. You can see the complete list of today’s Zacks #1 Rank stocks here.
Cross Country Healthcare delivered a trailing four-quarter earnings surprise of 41.5%, on average. CCRN’s shares have surged 88.1% in the past year.
Accenture carries a Zacks Rank #2 (Buy). The company has an expected earnings growth rate of 19.8% for the current year. It delivered a trailing four-quarter earnings surprise of 5.3%, on average.
Accenture’s shares have surged 22.9% in the past year. The company has a long-term earnings growth of 10%.
Clean Harbors’ carries a Zacks Rank #1. The company pulled off a trailing four-quarter earnings surprise of 43.2%, on average.
CLH’s shares have jumped 9.4% in the past year.